Aktien Sensor

Zimmer Biomet Holdings Inc. has secured approval from Japan’s PMDA for its new hip replacement systems, iTaperloc Complete and iG7 Hip System, marking a significant regulatory milestone and expanding the company’s presence in the orthopedic market.

Abbott Laboratories’ diagnostics division continues to drive growth and stability, despite recent stock price volatility and external challenges, making it an attractive option for income-focused investors.

McKesson Corporation’s stock has seen a significant surge in recent days, driven by bullish revisions from major investment houses and a consensus view that the company’s prospects are improving, with analysts setting a target price as high as $860.

Humana Inc. has secured a favorable ruling in a Medicare Advantage lawsuit, reinforcing its compliance posture and stability of revenue streams, while also continuing to invest in innovation and precision healthcare solutions.

ResMed Inc., a leading medical device company, has reported sustained growth in its share price and market capitalization, driven by its expertise in sleep-disordered breathing devices and strategic positioning in the expanding smart sleep tracker m…

Cencora Inc.’s stock price rises 1.98% on the NYSE, driven by a Relative Strength Rating upgrade and analyst sentiment, but a deeper analysis of the company’s financials and regulatory landscape reveals a more nuanced picture with both opportunities…

Zimmer Biomet Holdings Inc. has secured its first iodine-technology orthopedic implant approval in Japan, a regulatory milestone that is expected to bolster the company’s competitive standing in the global market and drive revenue growth.

Siemens Healthineers AG continues to solidify its position as a leader in medical technology through strategic partnerships, talent acquisitions, and a focus on core product categories, despite a volatile macroeconomic environment.

STERIS PLC, a global infection prevention and procedural products company, has seen its shares more than double in value over the past two years, driven by strong operational performance, strategic innovation, and a favorable reimbursement climate, …

Alcon AG’s share price declined amid market volatility, raising concerns about the company’s valuation and the pending acquisition of STAAR Surgical, but its long-term prospects remain strong due to its position in the growing ophthalmic device mark…